- Home
- CRGY vs BIRK Comparison
CRGY vs BIRK Comparison
Compare CRGY & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CRGY | BIRK |
|---|---|---|
| Founded | 1986 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.4B |
| IPO Year | 2022 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CRGY | BIRK |
|---|---|---|
| Price | $11.62 | $36.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 23 |
| Target Price | $18.69 | ★ $50.90 |
| AVG Volume (30 Days) | ★ 8.5M | 1.8M |
| Earning Date | 11-02-2026 | 12-10-2026 |
| Dividend Yield | ★ 4.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $3,579,782,000.00 | N/A |
| Revenue This Year | $41.06 | $11.96 |
| Revenue Next Year | $23.05 | $13.75 |
| P/E Ratio | $99.08 | ★ $17.48 |
| Revenue Growth | ★ 22.14 | N/A |
| 52 Week Low | $7.68 | $29.93 |
| 52 Week High | $15.47 | $50.73 |
Technical Indicators
Market Signals| Indicator | CRGY | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 38.19 | 58.51 |
| Support Level | $11.45 | $36.35 |
| Resistance Level | $11.69 | $37.05 |
| Average True Range (ATR) | 0.53 | 1.26 |
| MACD | -0.25 | 0.40 |
| Stochastic Oscillator | 28.67 | 69.02 |
Price Performance
Historical ComparisonAbout CRGY Crescent Energy Company
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The company operates in one reportable segment, which is the exploration and production of crude oil, natural gas, and NGLs.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.